These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3811724)

  • 1. [Course of Duchenne muscular dystrophy and its treatment].
    Kavtaradze NP; Mindadze BA; Natriashvili GD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(11):1638-41. PubMed ID: 3811724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of retabolyl on the dynamics of urinary catecholamine and DOPA excretion and electroneuromyographic indices in patients with Duchenne's myodystrophy].
    Badalian LO; Temin PA; Amanova ZN; Avakian GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(11):1630-5. PubMed ID: 6441403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early and late results of treatment with anabolic steroids of progressive muscular dystrophy].
    Zwoździak W; Zgorzalewicz B
    Neurol Neurochir Pol; 1967; 1(3):345-51. PubMed ID: 6055670
    [No Abstract]   [Full Text] [Related]  

  • 4. [Discriminant analysis of methods for detecting the heterozygote carrier state for the Duchenne muscular dystrophy gene].
    Khrennikov VIu; Sitnikov VF; Deev AI; Svintsitskiĭ IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(11):14-8. PubMed ID: 3223151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening for deletion in patients with Duchenne's myodystrophy by multiplex amplification].
    Chukhrova AL; Malygina NA; Poliakov AV; Zaĭtseva SP; Sitnikov VF; Dadali EL; Kamennykh LN; Khrennikov VIu; Badalian LO; Evgrafov OV
    Tsitol Genet; 1994; 28(4):80-3. PubMed ID: 7801388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of allopurinol in Duchenne's muscular dystrophy.
    Hunter JR; Galloway JR; Brooke MM; Kutner MH; Rudman D; Vogel RL; Wardlaw CF; Gerron GG
    Arch Neurol; 1983 May; 40(5):294-9. PubMed ID: 6847424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopurinol in Duchenne's muscular dystrophy.
    Thomson WH; Smith I
    N Engl J Med; 1978 Jul; 299(2):101. PubMed ID: 661858
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of molecular and genetic approaches in prenatal diagnosis and prevention of hemophilia A and Duchenne muscular dystrophy].
    Baranov VS; Aseev MV; Gorbunova VN; Ivashchenko TE; Mikhaĭlov AV; Gornostaeva NI; Surin VL
    Akush Ginekol (Mosk); 1990 Nov; (11):26-8. PubMed ID: 2077907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: controlled trials show no effect of allopurinol or ribose.
    Griffiths RD; Cady EB; Edwards RH; Wilkie DR
    Muscle Nerve; 1985; 8(9):760-7. PubMed ID: 3935926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Present-day clinico-genetic framework of Duchenne's muscular dystrophy].
    Meola G
    Riv Neurol; 1989; 59(1):8-14. PubMed ID: 2669113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myoblast transfer in the treatment of Duchenne's muscular dystrophy.
    Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R
    N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duchenne's muscular dystrophy in six siblings. The case for early diagnosis and neonatal screening.
    Moosa A
    S Afr Med J; 1982 Nov; 62(21):765-7. PubMed ID: 7135141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with medico-genetic counseling of the families of patients with Duchenne muscular dystrophy].
    Krasil'nikov VV; Lazebnik TA; Shilov LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(3):338-40. PubMed ID: 3577524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The dystrophin gene structure in patients with Duchenne myodystrophy].
    Krakhmaleva IN; Lipatova NA; Shishkin SS; Shakhovskaia NI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(3):41-3. PubMed ID: 10205842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Etiopathogenesis and diagnosis of Duchenne's myodystrophy].
    Morrone G; Cappello A
    Pediatria (Napoli); 1978 Jun; 86(2):337-45. PubMed ID: 360157
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenatal diagnosis and detection of carriers with DNA probes in Duchenne's muscular dystrophy.
    Darras BT; Harper JF; Francke U
    N Engl J Med; 1987 Apr; 316(16):985-92. PubMed ID: 3561454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Duchenne's myopathy, current trends].
    Guibaud P
    Pediatrie; 1983; 38(1):57-62. PubMed ID: 6346252
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic delay in Duchenne's muscular dystrophy.
    Crisp DE; Ziter FA; Bray PF
    JAMA; 1982 Jan 22-29; 247(4):478-80. PubMed ID: 7054550
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of dystrophin expression after activation of myogenesis in amniocytes, chorionic-villus cells, and fibroblasts. A new method for diagnosing Duchenne's muscular dystrophy.
    Sancho S; Mongini T; Tanji K; Tapscott SJ; Walker WF; Weintraub H; Miller AD; Miranda AF
    N Engl J Med; 1993 Sep; 329(13):915-20. PubMed ID: 8361505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.